Subgroups analysis of a multicenter, prospective, randomized, blinded phase 2b trial of trastuzumab plus nelipeptimut-S (NeuVax) vs trastuzumab for prevention of recurrence in breast cancer patients
CANCER RESEARCH（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined